PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
+2.9%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$4.5B
AUM Growth
+$4.5B
(-0.88%)
Cap. Flow
-$82.1M
Cap. Flow
% of AUM
-1.82%
Top 10 Holdings %
Top 10 Hldgs %
51.71%
Holding
90
New
6
Increased
21
Reduced
17
Closed
10
Top Buys
| 1 |
VanEck Gold Miners ETF
GDX
|
$82.9M |
| 2 |
Gilead Sciences
GILD
|
$80M |
| 3 |
Skyworks Solutions
SWKS
|
$62.4M |
| 4 |
LVLT
Level 3 Communications Inc
LVLT
|
$50.7M |
| 5 |
MGIC Investment
MTG
|
$31.1M |
Top Sells
| 1 |
YOKU
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
|
$116M |
| 2 |
Corning
GLW
|
$110M |
| 3 |
QLIK
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
|
$40.1M |
| 4 |
TSL
Trina Solar Limited
TSL
|
$35.5M |
| 5 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$29.9M |
Sector Composition
| 1 | Technology | 18.82% |
| 2 | Communication Services | 18.79% |
| 3 | Consumer Discretionary | 17.54% |
| 4 | Industrials | 12.41% |
| 5 | Financials | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Revvity
RVTY
$10.5B
| $2.66M | 0.06% | 53,700 +16,000 | +42% | +$791K |
|
|
FMI
52
DELISTED
Foundation Medicine, Inc.
FMI
| $2.33M | 0.05% | 128,000 +73,000 | +133% | +$1.33M |
|
53
Incyte
INCY
$16.5B
| $2.24M | 0.05% | 30,864 +15,000 | +95% | +$1.09M |
|
54
Icon
ICLR
$13.8B
| $2.14M | 0.05% | +28,500 | New | +$2.14M |
|
55
Johnson & Johnson
JNJ
$427B
| $1.9M | 0.04% | 17,600 +6,000 | +52% | +$649K |
|
56
Ironwood Pharmaceuticals
IRWD
$214M
| $1.89M | 0.04% | 173,000 +53,000 | +44% | +$580K |
|
57
Groupon
GRPN
$1.06B
| $1.62M | 0.04% | 407,000 | – | – |
|
|
ARIA
58
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $1.6M | 0.04% | 250,300 +138,000 | +123% | +$882K |
|
|
AERI
59
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.48M | 0.03% | 122,000 | – | – |
|
60
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.42M | 0.03% | 17,220 | – | – |
|
61
Pfizer
PFE
$141B
| $1.41M | 0.03% | 47,610 | – | – |
|
62
LivaNova
LIVN
$3.08B
| $1.29M | 0.03% | 23,982 | – | – |
|
63
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.29M | 0.03% | +46,000 | New | +$1.29M |
|
|
CFMS
64
DELISTED
Conformis, Inc. Common Stock
CFMS
| $1.2M | 0.03% | +112,000 | New | +$1.2M |
|
|
SGEN
65
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.19M | 0.03% | 34,000 | – | – |
|
66
Cardinal Health
CAH
$35.5B
| $1.15M | 0.03% | 14,000 | – | – |
|
|
INFI
67
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.09M | 0.02% | 206,932 +60,000 | +41% | +$316K |
|
68
Verastem
VSTM
$569M
| $1.09M | 0.02% | 688,924 | – | – |
|
69
Biogen
BIIB
$19.4B
| $1.04M | 0.02% | 4,000 -2,500 | -38% | -$651K |
|
|
EMC
70
DELISTED
EMC CORPORATION
EMC
| $1.01M | 0.02% | 38,000 | – | – |
|
71
Merck
MRK
$210B
| $994K | 0.02% | 18,800 | – | – |
|
|
JUNO
72
DELISTED
Juno Therapeutics, Inc.
JUNO
| $948K | 0.02% | 24,895 -15,105 | -38% | -$575K |
|
73
RTX Corp
RTX
$212B
| $800K | 0.02% | 8,000 -10,000 | -56% | -$1M |
|
|
IMGN
74
DELISTED
Immunogen Inc
IMGN
| $771K | 0.02% | 90,600 | – | – |
|
75
Veeco
VECO
$1.48B
| $487K | 0.01% | 25,000 | – | – |
|